In challenge to Trump, geneticist Michael Eisen announces Senate run to ‘bring science’ to Congress

WEB eisen michael edit

Michael Eisen, a geneticist at the University of California, Berkeley, [has]…announced on Twitter that he will run for US Senate in 2018…Nature caught up with Eisen to ask him about his plans.

What made you decide to run?

This election, and in particular, everybodyโ€™s worst fears about the new administrationโ€™s attitudes. Not toward science in the narrow sense…but the basic rejection of the fundamental principles upon which science is based.ย Iโ€™ve long thought that thereโ€™s been a dearth of scientific engagement with politics in general.

Why the Senate?

Thatโ€™s the place where the issues are in focus. I keep wanting to see a scientist in these hearings on all these presidential appointees, who can ask them questions that a scientist would ask. There are a few scientists in the House, but there arenโ€™t any in the Senate.

Whatโ€™s your platform?

This is not about fighting for science funding: scientists feel like not just our voice, but our perspective is not well represented in politics. And because politicians have ignored or have been outright attacking science, so much of what we believe in is under threat. Weโ€™re paying the price for having been politically disengaged for such a long time.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:ย Geneticist launches bid for US Senate

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint โ€” Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDAโ€™s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTCโ€”a great idea. Hereโ€™s why itโ€™s unlikely to happen
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.